Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl) piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor

Journal of Medicinal Chemistry

Volumn 48, Issue 3, 2005, Pages 839-848

  Grundt, Peter ^a   Carlson, Erin E ^a   Cao, Jianjing ^a   Bennett, Christina J ^a   McElveen, Elizabeth ^b   Taylor, Michelle ^b   Luedtke, Robert R ^b   Newman, Amy Hauck ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMIDE DERIVATIVE; DOPAMINE 3 RECEPTOR; N [4 [4 (2,3 DICHLOROPHENYL)PIPERAZIN 1 YL]BUT 2 ENYL] 4 PYRIDIN 2 YLBENZAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; CONTROLLED STUDY; EVALUATION; MITOGENESIS; MOLECULAR DYNAMICS; MOLECULAR PROBE; NONHUMAN; RECEPTOR BINDING;

ANIMALS; BENZAMIDES; BINDING, COMPETITIVE; CELL LINE; CRICETINAE; CRICETULUS; HUMANS; LIGANDS; PIPERAZINES; PYRIDINES; QUINPIROLE; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 13444287717     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049465g     Document Type: Article

References (23)

1. 3) as a target for neuroleptics. Nature 1990, 347, 146-151.
2. Schwartz, J. C.; Levesque, D.; Martres, M. P.; Sokoloff, P. Dopamine-D(3) receptor - Basic and clinical aspects. Clin. Neuropharmacol. 1993, 16, 295-314.
3. 3 dopamine receptor: Neurobiology and potential clinical relevance. Pharmacol. Rev. 1997, 49, 231-252.
4. Pilla, M.; Perachon, S.; Sautel, F.; Garrido, F., Mann, A.; Wermuth, C. G.; Schwartz, J. C.; Everitt, B. J.; Sokoloff, P. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D-3 receptor agonist. Nature 1999, 400, 371-375.
5. Beardsley, P. M.; Sokoloff, P.; Balster, R. L.; Schwartz, J. C. The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered. Behav. Pharmacol. 2001, 12, 1-11.
6. 3 receptor antagonist with high oral bioavailability and CNS penetration in the rat. J. Med. Chem. 2000, 43, 1878-1885.
7. 3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in Rats. J. Neurosci. 2002, 22, 9595-9603.
8. Di Ciano, P.; Underwood, R. J.; Hagan, J. J.; Everitt, B. J. Attenuation of cue-controlled cocaine-seeking by a selective DS dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 2003, 28, 329-338.
9. Luedtke, R. R.; Mach, R. H. Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders. Curr. Pharm. Design 2003, 9, 643-671.
10. Macdonald, G. J.; Branch, C. L.; Hadley, M. S.; Johnson, C. N.; Nash, D. J.; Smith, A. B.; Stemp, G.; Thewlis, K. M.; Vong, A. K. K.; Austin, N. E.; Jeffrey, P.; Winborn, K. Y.; Boyfield, I.; Hagan, J. J.; Middlemiss, D. N.; Reavill, C.; Riley, G. J.; Watson, J. M.; Wood, M.; Parker, S. G.; Ashby, C. R. Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl)) phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro1H-3- benzazepine (SB-414796): A potent and selective dopamine D-3 receptor antagonist. J. Med. Chem. 2003, 46, 4952-4964.
11. Leopoldo, M.; Berardi, F.; Colabufo, N. A.; De Giorgio, P.; Lacivita, E.; Perrone, R.; Tortorella, V. Structure - affinity relationship study on N-4-(4-arylpiperazin-1-yl)butyl arylcarboxamides as potent and selective dopamine D-3 receptor Ligands. J. Med. Chem. 2002, 45, 5727-5735.
12. Bettinetti, L.; Schlotter, K.; Hubner, H.; Gmeiner, P. Interactive SAR studies: Rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists. J. Med. Chem. 2002, 45, 4594-4597.
13. Hackling, A. E.; Stark, H. Dopamine D-3 receptor ligands with antagonist properties. Chembiochem 2002, 3, 946-961.
14. Hackling, A.; Ghosh, R.; Perachon, S.; Mann, A.; Holtje, H. D.; Wermuth, C. G.; Schwartz, J. C.; Sippl, W.; Sokoloff, P.; Stark, H. N-(w-(4-(2- Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands. J. Med. Chem. 2003, 46, 3883-3899.
15. 3 receptor antagonists. Bioorg. Med. Chem. Lett. 2003, 13, 2179-2183.
16. 3 receptor antagonists. Bioorg. Med. Chem. Lett. 1998, 8, 2715-2718.
17. Robarge, M. J.; Husbands, S. M.; Kieltyka, A.; Brodbeck, R.; Thurkauf, A.; Newman, A. H. Design and synthesis of (2,3-dichlorophenyl)piperazin-1-yl alkylfluorenylcarboxamides as novel ligands selective for the dopamine D-3 receptor subtype. J. Med. Chem. 2001, 44, 3175-3186.
18. 125I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors. Synapse 2000, 38, 438-449.
19. Van der Graaf, P. H.; Wayman, C. P.; Baxter, A. D.; Cook, A. S.; Wong, S. K.-F. WO Patent 03051370, 2003; Chem. Abstr. 2003, 139, 63348.
20. Connell, R. D.; Helquist, P.; Aakermark, B. New methodology for the synthesis of protected, primary pentadienylamines. J. Org. Chem. 1989, 54, 3359-3370.
21. Gong, Y.; Pauls, H. W. A convenient synthesis of heteroaryl benzoic acids via Suzuki reaction. Synlett 2000, 829-831.
22. Hagedorn, A. A.; Erhardt, P. W.; Lumma, W. C.; Wohl, R. A.; Cantor, E.; Chou, Y. L.; Ingebretsen, W. R.; Lampe, J. W.; Pang, D.; Pease, C. A.; Wiggins, J. Cardiotonic agents. 2. (Imidazolyl)-aroylimidazolones, highly potent and selective positive inotropic agents. J. Med. Chem. 1987, 30, 1342-1347.
23. 50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.